On November 7, Novartis (China) and Royal Philips (China) once again signed a global strategic cooperation memorandum at the 7th China International Import Expo. It is reported that this strategic cooperation will focus on more innovative possibilities in the field of neuroimmune diseases.
诺华与飞利浦再度签署战略合作备忘录
Novartis and Royal Philips have once again signed a global strategic cooperation memorandum.
The translation is provided by third-party software.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.